A carregar...

Testosterone therapy in the new era of Food and Drug Administration oversight

The Food and Drug Administration (FDA) introduced changes in labeling and indications for use to testosterone products in 2015 due to a possible increased risk of cardiovascular (CV) events. This decision was made based on six clinical studies—some that supported an increased CV risk, and some that...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Androl Urol
Main Authors: Desroches, Bethany, Kohn, Taylor P., Welliver, Charles, Pastuszak, Alexander W.
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4837303/
https://ncbi.nlm.nih.gov/pubmed/27141448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2016.03.13
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!